Melinta Therapeutics
Manufacturing · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
389 Interpace Pkwy Ste 450, Parsippany, ...Phone Number
(908) 617-1309Website
www.melinta.comRevenue
$96.4 MillionIndustry
About Melinta Therapeutics
CorMedix Therapeutics is focused on developing and commercializing therapeutic products aimed at treating life-threatening diseases and conditions. Their primary product, DefenCath, combines taurolidine and heparin for medical use. The company targets healthcare providers and institutions that require innovative solutions for critical health issues. Additionally, CorMedix engages in research and clinical trials to expand its product pipeline.Explore more
Melinta Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Melinta Therapeutics
Compare insights from companies similar to Melinta Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Melinta Therapeutics
$96.4M
201-500
Private
$30M
2000
JS
Jennifer SanfilippoGeneral Counsel & Chief Compliance Officer
Melinta Therapeutics Tech Stack
A closer look at the technologies used by Melinta Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Melinta Therapeutics
Sign Up For FreeTo access detailed company insights
CorMedix Therapeutics is focused on developing and commercializing therapeutic products aimed at treating life-threatening diseases and conditions. Their primary product, DefenCath, combines taurolidine and heparin for medical use. The company targets healthcare providers and institutions that require innovative solutions for critical health issues... Read More
